Breast Cancer
Particularly useful prophylactic administration of the drug is for the fair sex, who are particularly at risk because of the threat of breast cancer . Above all, this woman among relatives who have already been cases of the disease. During study 7151 women aged 35 to 70 years old, at risk, I received within 5 years or 20 mg of tamoxifen daily or such as the amount of a placebo for five years.
At the end of the experiment the health of these women were followed for an additional 16 years. It turned out that 350 Volunteers in the group on placebo developed breast cancer. In the group treated Tamoxifen, 251 sick woman. Thus, reduction of cancer risk by tamoxifen was 29%. But the risk of estrogenpolozhitelnogo invasive breast cancer, which accounts for two-thirds of all cases disease was reduced by 35%. (READ MORE)
Industry News
Go back to the main page
Немає коментарів:
Дописати коментар